INSULFRAX PUMPABLE

Hazard statements (CLP)

H317

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS07

Signal word

Warning

Contains

2-methyl-2H-isothiazol-3-one

Hazard statements

H317 - May cause an allergic skin reaction.

Precautionary statements

P261 - Avoid breathing mist, spray. P280 - Wear protective gloves, eye protection, face protection. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component AES wool (synthetic fibres, alkaline earth silicate) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (436083-99-7) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 2-methyl-2H-isothiazol-3-one (2682-20-4) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS07 Signal word (CLP)